Mostra Pubblicazioni per RCT   MOST    TUTTE GASTRICO OVARICO COLORETTALE PSEUDOMIXOMA MESOTELIOMA VARIE POLMONE PERFUSIONE ISOLATA D'ARTO RCT (Regional Cancer Therapies) COLORETTALE Comparison of Two Kinds of Intraperitoneal Chemotherapy Following Complete Cytoreductive Surgery of Colorectal Peritoneal Carcinomatosis Dominique Elias, MD, PhD, Emmanuel Benizri, MD, Daniela DiPietrantonio, MD, Paola Menegon, MD, David Malka, MD, PhD, and Bruno Raynard, MD Peritoneal carcinomatosis from colorectal cancer: HIPEC? G. Confuorto, M.E. Giuliano, A. Grimaldi, C. Viviano Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement J. Esquivel, R. Sticca, J. Esquivel, R. Sticca, P. Sugarbaker, E. Levine, T. D. Yan, R. Alexander, D. Baratti, D. Bartlett, R. Barone, P. Barrios, S. Bieligk, P. Bretcha-Boix, C. K. Chang, F. Chu, Q. Chu, S. Daniel, E. deBree, M. Deraco, L. Dominguez-Parra, D. Elias, R. Flynn, J. Foster, A. Garofalo, F. N. Gilly, 0. Glehen, A. Gomez Portilla, L. Gonzalez-Bayon, S. Gonzalez-Moreno, M. Goodman, V. Gushchin, N. Hanna, J. Hartmann, L. Harrison, R. Hoefer, J. Kane, D. Kecmanovic, S. KelIey, J. Kuhn, J. LaMont, J. Lange, B. Li, B. Loggie, H. Mahteme, G. Mann, R. Martin, R. A. Misih, B. Moran, D. Morris, L. Onate-Ocana, N. Petrelli, G. Philippe, J. Pingpank, A. Pitroff, P. Piso, M. Quinones, L. Riley, L. Rutstein, S. Saha, S. Alrawi, A. Sardi, S. Schneebaum, P. Shen, D. Shibata, J. Spellman, A. Stojadinovic, J. Stewart, J. Torres-Melero, T. Tuttle, V. Verwaal, J. Villar, N. Wilkinson, R. Younan, H. Zeh, F. Zoetmulder, and U. Sebbag Treatment of peritoneal carcinomatosis from colorectal cancer with cytoreductive surgery and perioperative intraperitoneat chemotherapy: State of the art and future prospects Isidoro Di Carlo, Elia Pulvirenti, Francesca Sparatore, Adriana Toro, Stefano Cordio Il ruolo della chemioipertermia nel carcinoma del colon-retto F. Roviello, D. Marrelli, C. Pedrazzani Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy in the Management of Peritoneal Surface Malignancies of Colonic Origin: A Consensus Statement J. Esquivel,1 R. Sticca,2 P. Sugarbaker,3 E. Levine,4 T. D. Yan,3 R. Alexander,5 D. Baratti,6 D. Bartlett,7 R. Barone,8 P. Barrios,9 S. Bieligk,10 P. Bretcha-Boix,11 C. K. Chang,12 F. Chu,13 Q. Chu,14 S. Daniel,13 E. deBree,15 M. Deraco,6 L. Dominguez-Parra,16 D. Elias,17 R. Flynn,10 J. Foster,18 A. Garofalo,19 F. N. Gilly,20 O. Glehen,20 A. Gomez-Portilla,21 L. Gonzalez-Bayon,22 S. Gonzalez-Moreno,23 M. Goodman,24 V. Gushchin,25 N. Hanna,5 J. Hartmann,26 L. Harrison,27 R. Hoefer,28 J. Kane,29 D. Kecmanovic,30 S. Kelley,31 J. Kuhn,32 J. LaMont,32 J. Lange,33 B. Li,14 B. Loggie,18 H. Mahteme,34 G. Mann,35 R. Martin,36 R. A. Misih,37 B. Moran,38 D. Morris,13 L. Onate-Ocana,39 N. Petrelli,37 G. Philippe,40 J. Pingpank,41 A. Pitroff,1 P. Piso,42 M. Quinones,43 L. Riley,44 L. Rutstein,45 S. Saha,46 S. Alrawi,29 A. Sardi,25 S. Schneebaum,47 P. Shen,4 D. Shibata,31 J. Spellman,48 A. Stojadinovic,49 J. Stewart,4 J. Torres-Melero,50 T. Tuttle,51 V. Verwaal,52 J. Villar,53 N. Wilkinson,54 R. Younan,6 H. Zeh,7 F. Zoetmulder,52 and G. Sebbag55 Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for the Management of Peritoneal Carcinomatosis From Colorectal Cancer: A Multi-Institutional Study O. Glehen, F. Kwiatkowski, P.H. Sugarbaker, D. Elias, E.A. Levine, M. De Simone, R. Barone, Y. Yonemura, F. Cavaliere, F. Quenet, M. Gutman, A.A.K. Tentes, G. Lorimier, J.L. Bernard, J.M. Bereder, J. Porcheron, A. Gomez-Portilla, P. Shen, M. Deraco, and P. Rat Heated intra-operative intraperitoneal oxaliplatin alone and in combination with intraperitoneal irinotecan: Pharmacologic studies D. Elias, B. Raynard, M. Bonnay, M. Pocard Systematic Review on the Efficacy of Cytoreductive Surgery Combined With Perioperative Intraperitoneal Chemotherapy for Peritoneal Carcinomatosis From Colorectal Carcinoma Tristan D. Yan, Deborah Black, Renaldo Savady, and Paul H. Sugarbaker Peritoneal Carcinomatosis of Colorectal Origin Incidence and Current Treatment Strategies Manuel J. Koppe, MD, Otto C. Boerman, PhD, Wim J. G. Oyen, MD, PhD, and Robert P. Bleichrodt, MD, PhD Randomized Trial of Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy Versus Systemic Chemotherapy and Palliative Surgery in Patients With Peritoneal Carcinomatosis of Colorectal Cancer Vic J. Verwaal, Serge van Ruth, Eelco de Bree, Gooike W. van Slooten, Harm van Tinteren, Henk Boot, and Frans A.N. Zoetmulder Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin A.J. Witkamp, E. de Bree, M.M. Kaag, H. Boot, J.H. Beijnen, G.W. van Slooten, F. van Coevorden, F.A.N. Zoetmulder Trattamento delle carcinosi peritoneali mediante resezione seguita da chemioterapia intraperitoneale:aspetti pratici Elias D., Ducreux M., Reynaud B., Pocard M., Lasser P. Sitilo Experience on Peritoneal Carcinomatosis From Colorectal Cancer: Clinical Prognostic Features Cavaliere F., Rossi C.R., Deraco M., DeSimone M., DiFilippo S. Sitilo 2003 Peritoneal carcinomatosis of colorectal cancer: incidence, prognosis, and treatment modalities C. Knorr, B. Reingruber, T. Meyer, W. Hohenberger, C. Stremmel Peritoneal Carcinomatosis of Colorectal Origin Incidence and Current Treatment Strategies Manuel J. Koppe, MD,Otto C. Boerman, PhD, Wim J. G. Oyen, MD, PhD, Robert P. Bleichrodt, MD, PhD Colon cancer prevalence and estimation of differing care needs of colon cancer patients G. Gatta, R. Capocaccia, F. Berrino, M. R. Ruzza, P. Costiero, EUROPREVAL Working Group Bowel Complications in 203 Cases of Peritoneal Surface Malignancies Treated With Peritonectomy and Closed-Technique Intraperitoneal Hyperthermic Perfusion Rami Younan, MD, Shigeki Kusamura, MD, Dario Baratti, MD, Grazia Daniela Oliva, MD, Pasqualina Costanzo, MD, Myriam Favaro, MD, Cecilia Gavazzi, MD, Marcello Deraco, MD Heated intra-operative intraperitoneal oxaliplatin after complete resection of peritoneal carcinomatosis:pharmacokinetics and tissue distribution D. Elias, M. Bonnay, J. M. Puizillou, S. Antoun, S. Demirdjian, A. El Otmany, J. P. Pignon, L. Drouard-Troalen, J. F. Ouellet & M. Ducreux GASTRICO Early Postoperative Intraperitoneal Chemotherapy Following Cytoreductive Surgery in Patients with Very Advanced Gastric Cancer Jae-Ho Cheong, MD, Jia Yun Shen, MD, Chang Soo Song, MD, Woo Jin Hyung, MD, Jian Guo Shen, MD, Seung Ho Choi, MD, and Sung Hoon Noh, MD Gastric cancer Charles D. Blanke, MD, Lawrence R. Coia, MD, Roderich E. Schwarz, MD, PhD, and Steven R. Bonin, MD Cytoreductive Surgery and Intraperitoneal Chemohyperthermia for Peritoneal Carcinomatosis arising from Gastric Cancer Gilly N., Glehen O. Peritoneal carcinomatosis from digestive tract cancer: new management by cytoreductive surgery and intraperitoneal chemohyperthermia Olivier Glehen, Faheez Mohamed, and François N Gilly NCI Clinical Announcement: Intraperitoneal chemotherapy for ovarian cancer Armstrong at all Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer Deborah K. Armstrong, M.D., Brian Bundy, Ph.D., Lari Wenzel, Ph.D., Helen Q. Huang, M.S., Rebecca Baergen, M.D., Shashikant Lele, M.D., Larry J. Copeland, M.D., Joan L. Walker, M.D., and Robert A. Burger, M.D., for the Gynecologic Oncology Group Cytoreduction combined with intraperitoneal hyperthermic perfusion chemotherapy in advanced/recurrent ovarian cancer patients: The experience of National Cancer Institute of Milan F. Raspagliesi, S. Kusamura, J.C. Campos Torres, G.A. de Souza, A. Ditto, F. Zanaboni, R. Younan PERFUSIONE ISOLATA D'ARTO Isolated limb perfusion for melanoma patients—a review of its indications and the role of tumour necrosis factor-a D.J. Gru¨nhagen, J.H.W. de Wilt, A.N. van Geel, A.M.M. Eggermont* Isolated limb perfusion with tumour necrosis factor-alpha and melphalan with or without interferon-gamma for the treatment of in-transit melanoma metastases: a multicentre randomized phase II study. Lienard D, Eggermont AM, Koops HS, Kroon B, Towse G, Hiemstra S, Schmitz P, Clarke J, Steinmann G, Rosenkaimer F, Lejeune FJ. POLMONE Combined regional and systemic chemotherapy for advanced and inoperable non-small cell lung cancer H. Muller Intrapleural Hyperthermic Perfusion with Chemotherapy increases Apoptosis in Malignant Pleuritis Yasunori Matsuzaki Regional plus systemic chemotherapy: an effective treatment in recurrent non-small cell lung cancer H. Muller, S.Guadagni Resection and Perfusion Thermochemotherapy: A New Approach for the Treatment of Thymic Malignancies With Pleural Spread Yael Refaely, MD, David A. Simansky, MD, Michael Paley, MD, Maya Gottfried, MD, and Alon Yellin, MD Pleural Perfusion Thermo-Chemotherapy Under VATS: A New Less Invasive Modality for Advanced Lung Cancer With Pleural Spread Norihisa Shigemura, MD, Akinori Akashi, MD, Tomoyuki Nakagiri, MD, Kenji Hazama, MD, Mitsunori Ohta, MD, and Hikaru Matsuda, MD Contemporary Management of Malignant Pleural Mesothelioma Eric G. Butchart MESOTELIOMA Prognostic Indicators for Patients Undergoing Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma Tristan D. Yan, BSc (Med) MBBS, Erwin A. Brun, MD, Carlos A. Cerruto, MD, Namik Haveric, MD, David Chang, MS, and Paul H. Sugarbaker, MD Morbidity and Mortality Assessment of Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Diffuse Malignant Peritoneal Mesothelioma - A Prospective Study of 70 Consecutive Cases Tristan D. Yan, BSc (Med) MBBS, Gary Edwards, PA-C, Robert Alderman, PA-C, Christina E. Marquardt, RN, and Paul H. Sugarbaker, MD Peritoneal Mesothelioma Treated by Induction Chemotherapy, Cytoreductive Surgery, and Intraperitoneal Hyperthermic Perfusion Marcello Deraco, Md, Paolo Casali, M.G. Inglese, Dario Baratti, Elisabetta Pennacchioli, Rossella Bertulli, Shigeki Kusamura Prognostic Analysis of Clinicopathologic Factors in 49 Patients With Diffuse Malignant Peritoneal Mesothelioma Treated With Cytoreductive Surgery and Intraperitoneal Hyperthermic Perfusion Marcello Deraco, MD, Daisuke Nonaka, MD, Dario Baratti, MD, Paolo Casali, MD, Juan Rosai, MD, Rami Younan, MD, Salvatore Andreola S, MD, Antonello Domenico Cabras AD, MD, Shigeki Kusamura, MD Advances in Malignant Mesothelioma Bruce W.S. Robinson, M.D., and Richard A. Lake, Ph.D Malignant mesothelioma Bruce W S Robinson, Arthur W Musk, Richard A Lake Diffuse Malignant Mesothelioma of the Peritoneum A Clinicopathologic Study of 35 Patients Treated Locoregionally at a Single Institution Daisuke Nonaka, M.D. Shigeki Kusamura, M.D., Dario Baratti, M.D., Paolo Casali, M.D. Peritoneal Mesothelioma Treated by Cytoreductive Surgery and Intraperitoneal Hyperthermic Chemotherapy: Results of a Prospective Study C. Brigand, MD, O. Monneuse, MD, F. Mohamed, MBChB, MRCS, A. C. Sayag-Beaujard, MD, S. Isaac, MD, F. N. Gilly, MD, PhD, O. Glehen,MD, PhD Mesotelioma Peritoneale: Aspetti biologici condizionanti nuovi orientamenti terapeutici M.Deraco, N.Zaffaroni, D.Baratti, P.Casali, S.Kusamura Comprehensive management of diffuse malignant peritoneal mesothelioma P.H. Sugarbaker*, T.D. Yan, O.A. Stuart, D. Yoo VARIE Learning Curve for Cytoreductive Surgery and Perioperative Intraperitoneal Chemotherapy for Peritoneal Surface Malignancy - A Journey to Becoming a Nationally Funded Peritonectomy Center Tristan D. Yan, BSc (Med) MBBS, Matthew Links, MBBS PhD, Sal Fransi, MBBS, Theresa Jacques, MBBS, Deborah Black, BSc DipEd MStat PhD, Vanessa Saunders, BNMN, and David L. Morris, MD PhD Cytoreductive Surgery and Intraoperative Hyperthermic Intraperitoneal Chemotherapy with Paclitaxel: A Clinical and Pharmacokinetic Study Eelco deBree, MD, Hilde Rosing, PhD, Dimitris Filis, MD, John Romanos, MD, Maria Melisssourgaki, Markos Daskalakis, MD, Maria PiIatou, Elias Sanidas, MD, Panagiotis Taflampas, MD, Konstantinos Kalbakis, MD, Jos H. Beijnen, PhD, and Dimitris D. Tsiftsis, MD Hyperthermic intraperitoneal chemoperfusion is an option for treatment of peritoneal carcinomatosis in children Bertram Reingruber, M.I. Boettcher, P. Klein, W. Hohenberger, J.O.W. Pelz Limited Survival in Patients With Carcinomatosis From Foregut Malignancies After Cytoreduction and Continuous Hyperthermic Peritoneal Perfusion Jeffrey M. Farma, M.D., James F. Pingpank, M.D., Steven K. Libutti, M.D., David L. Bartlett, M.D., Susan Ohl, R.N., Tatiana Beresneva, M.D., H. Richard Alexander, M.D. Update on Chemotherapeutic Agents Utilized for Perioperative Intraperitoneal Chemotherapy Sugarbaker et al 10 (2) 112 - The Oncologist Regional Chemotherapy for Solid Tumors Vaglini M, Deraco M, Pennacchioli E. Tumore mucinoso dell'appendice con estensioneperitoneale: nuove prospettive diagnostiche terapeutiche M.Deraco, S.Kusamura, D.Baratti, D.Nonaka, A.Kabras, J.Rosai Intraoperative modality of treatment for peritoneal carcinomatosis: use of hyperthermic intraperitoneal chemoperfusion Sutton SW., McCarty TM., Loggie BW. Semi-ClosedQ1 Hyperthermic-Antiblastic Peritoneal Perfusion (HAPP) in the Treatment of Peritoneal Carcinosis M.DeSimone Toxicity of Cytoreductive Surgery and Hyperthermic Intra-Peritoneal Chemotherapy Zoetmulder F.A.N., Verwaal V. Laparoscopic intraperitoneal hyperthermic chemotherapy for palliation of debilitating malignant ascites A. Garofalo, M. Valle, J. Garcia, P.H. Sugarbaker Heating the patient: a promising approach? J.Van der Zee Safety considerations for operating room personnel during hyperthermic intraoperative intraperitoneal chemotherapy perfusion L. Gonzalez-Bayon, S. Gonzalez-Moreno, G. Ortega-Perez Innovative therapies: intraoperative intracavitary chemotherapy Chang MY, Sugarbaker DJ. Trattamento chirurgico ad intendimento curativo nelle carcinosi peritoneali D.Elias Safety Monitoring of the Coliseum Technique for Heated Intraoperative Intraperitoneal Chemotherapy With Mitomycin C O. Anthony Stuart, BS, Arvil D. Stephens, BS, Laura Welch, MD, and Paul H. Sugarbaker, MD Future Perspectives of Interstitial and Perfusional Hyperthermia Gian Franco Baronzio, Michele De Simone, Gianmaria Fiorentini, Salvatore D’Angelo and E. Dieter Hager Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Surface Malignancy: Current Status and Future Directions John H. Stewart IV, MD, Perry Shen, MD, and Edward A. Levine, MD Perioperative morbidity and quality of life in long-term survivors following cytoreductive surgery and hyperthermic intraperitoneal chemotherapy U. Schmidta, M.H. Dahlke, J. Klempnauera, H.J. Schlittb, P. Piso Long-Term Survivorship and Quality of Life After Cytoreductive Surgery Plus Intraperitoneal Hyperthermic Chemotherapy for Peritoneal Carcinomatosis Richard P. McQuellon, PhD, Brian W. Loggie, MD, Anna B. Lehman, MA, Gregory B. Russell, MS, Ronald A. Fleming, PharmD, Perry Shen, MD, and Edward A. Levine, MD Complete cytoreduction and heated intraoperative intraperitoneal chemotherapy (the Sugarbaker technique) for peritoneal carcinomatosis NICE National lntitute of Clinical Excellence The approval process for hyperthermic intraoperative intraperitoneal chemotherapy P.H. Sugarbaker, L. Clarke Cancer prevalence in European registry areas A. Micheli, E. Mugno, V. Krogh, M. J. Quinn, M. Coleman, T. Hakulinen, G. Gatta, F. Berrino, R. Capocaccia, EUROPREVAL Working Group Investigations on safety of hyperthermic intraoperative intraperitoneal chemotherapy (HIPEC) with Mitomycin C K. Schmid, M.I. Boettcher, J.O.W. Pelz, T. Meyer, G. Korinth, J. Angerer, H. Drexler Computerization and electronic integration in the optimization of biomedical system for the hyperthermic antiblastic perfusion in extracorporeal circulation Gattai R. , Mascitelli E., Pace M. The role of apoptotic or nonapoptotic cell death in determining cellular response to anticancer treatment R. Kima, M. Emib, K. Tanabeb, Y. Uchidac, K. Arihirod OVARICO Treatment of ovarian cancer using intraperitoneal chemotherapy with taxanes: From Laboratory bench to bedside Eelco de Bree,* Panayiotis A. Theodoropoulos, Hilde Rosing, John Michalakis, John Romanos, Jos H. Beijnen, Dimitris D. Tsiftsis Intraperitoneal chemotherapy for Patients with advanced ovarian cancer: A review of the evidence and standards for the delivery of care M. Fung-Kee-Fung, D. Provencher, B. Rosen, P. Hoskins, L. Rambout, T. Oliver, W. Gotlieb, A. Covens, and the IP Chemotherapy Working Group on behalf of the Society of Gynecologic Oncologists of Canada Treatment of ovarian cancer with paclitaxel – or carboplatin – based intraperitoneal hyperthermic chemotherapy during secondary surgery Jeong Hoon Bae, Joon Mo Lee, Ki Sung Ryu, Yong Seok Lee, Yong Gyu Park, Soo Young Hur, Woong Shik Ahn, Seong Eun Namkoong Management of peritoneal surface component of ovarian cancer M.Deraco, F.Raspagliesi, S.Kusamura Cytoreductive surgery followed by intraperitoneal hyperthermic perfusion in the treatment of recurrent epithelial ovarian cancer: a phase il clinical study Marcello Deraco, Carlo R Rossi, Elisabetta Pennacchioli, Stefano Guadagni, Danielle Carlier Somers Nicola Santoro, Francesco Raspagliesi, Shigeki Kusamura, Maurizio Vaglini Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer (Review) Jaaback K, Johnson N Intraperitoneal chemotherapy for the initial management of primary epithelial ovarian cancer (Review) Jaaback K, Johnson N Ovarian Cancer Study Is Hailed Associated Press January 5, 2006 Cytoreductive Surgery and Intraoperative Hyperthermic Chemoperfusion for Advanced Ovarian Carcinoma Advanced Ovarian Carcinoma Intraperotoneal hypertermic perfusion chemotherapy of patients with chemotherapy-resistant peritoneal dissiminated ovarian cancer E.D.Hager, H.Dziambor, D.Hohmann Intraperitoneal hyperthermic chemotherapy in ovarian cancer J. Gori, R. Castan˜ O, M. Tozianoy, D. HaBich, J. Staringerz, D.G.B. De Quiro´ S & N. Felciz PSEUDOMIXOMA Survival Analysis of Pseudomyxoma Peritonei Patients Treated by Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Robert M. Smeenk, MD, Vic J. Verwaal, MD, PhD, Ninja Antonini, MSc, and Frans A. N. Zoetmulder, MD, PhD Peritonectomy and Intraperitoneal Hyperthermic Perfusion (IPHP): A Strategy That Has Confirmed its Efficacy in Patients with Pseudomyxoma Peritonei Marcello Deraco, MD, Dario Baratti, MD, Maria Grazia Inglese, MD, Biagino Allaria, MD, Salvatore Andreola, MD, Cecilia Gavazzi, MD, and Shigeki Kusamura, MD Toxicity and mortality of cytoreduction and intraoperative hyperthermic intraperitoneal chemotherapy in pseudomyxoma peritonei—a report of 103 procedures R.M. Smeenk, V.J. Verwaal, F.A.N. Zoetmulder New standard of care for appendiceal epithelial neoplasms and pseudomyxoma peritonei syndrome? The LANCET 2006 Paul H Sugarbaker   stampa